Patent application number | Description | Published |
20080307837 | Convertible motorized latch - Disclosed is a convertible motorized latch that may be configured in either of a slam latch or a dead bolt latch configuration, just by desired selection and replacement of a minimal number of components, and which may be used on new (oem) equipment or in retrofit applications. In either preferred configuration, an electric motor contained within the latch housing operates to open or unlock the latch. Latch closure may be provided by spring actuation in a slam configuration or by further motor operation in a dead bolt configuration. Either present configuration may make use of an electrical feedback switch for signaling latch retraction while the dead bolt configuration may also include a second electrical feedback switch for signaling latch extension. A gear train may be incorporated within the latch housing to provide reduced speed and increased torque from the electric motor. | 12-18-2008 |
20090132090 | FIELD RETROFITTABLE REFRIGERATOR LOCK WITH TEMPERATURE MONITORING, TEMPERATURE BASED ACCESS CONTROL AND ALARMING - Disclosed are apparatus and methodology subject matters for temperature monitoring and controlled access to refrigerated medications. An electronically controlled lock is installed on a refrigerator used for storage of temperature sensitive medications. Lock access is given to individuals having differing levels of access authorization so that user level authorization holders may have access to stored medications. Supervisor level authorization holders may have access to stored medications and may also effect changes in lock settings including setting alarm levels. Alarm levels may be adjusted to monitor temperatures within the refrigerated storage area so that in the case that temperature fall outside preset limits, access to the stored medicines may be had only by those individuals having supervisory access authorization. | 05-21-2009 |
20110074543 | APPARATUS AND METHOD FOR ELECTRONIC ACCESS CONTROL - Apparatus and methodology for providing electronic access control are disclosed. In an exemplary configuration, a retrofittable electronic lock can be used to provide secure storage to an enclosure. A user interface and LCD visual display can be provided to permit convenient adjustment of system operational parameters. In certain embodiments, the electronic access control system includes master-slave control capabilities. In other embodiments, the electronic access control system includes inventory management capability. In still other embodiments, apparatus and methodologies provide the secure storage of the enclosure when the enclosure is being moved or otherwise transported from one location to another location. Various alternative arrangements may provide various alert features, as well as battery features which facilitate rapid replacement and/or reconfiguration. | 03-31-2011 |
20120038177 | CONVERTIBLE MOTORIZED LATCH - Disclosed is a convertible motorized latch that may be configured in either of a slam latch or a dead bolt latch configuration, just by desired selection and replacement of a minimal number of components, and which may be used on new (oem) equipment or in retrofit applications. In either preferred configuration, an electric motor contained within the latch housing operates to open or unlock the latch. Latch closure may be provided by spring actuation in a slam configuration or by further motor operation in a dead bolt configuration. Either present configuration may make use of an electrical feedback switch for signaling latch retraction while the dead bolt configuration may also include a second electrical feedback switch for signaling latch extension. A gear train may be incorporated within the latch housing to provide reduced speed and increased torque from the electric motor. | 02-16-2012 |
Patent application number | Description | Published |
20080299214 | Intervertebral Disc Repair, Methods and Devices Therefor - The present application discloses compositions, methods and devices for treatment of a degenerative intervertebral disc. A composition can comprise chondrocytes expressing type II collagen. These chondrocytes can be obtained from human cadavers up to about two weeks following death, and can be grown in vitro. The compositions can further comprise one or more biocompatible molecules. Treatment of a degenerative disc can comprise injecting or implanting a composition comprising the chondrocytes into a degenerative disc. | 12-04-2008 |
20110256095 | Tissue Matrix System - The present application discloses matrix compositions to support the repair of tissue defects such as an injury to tendon tissue, ligament tissue, vascular tissue, dermal tissue, or muscle tissue. A matrix described herein comprises a polyester polymer entangled with a polysaccharide polymer. Also disclosed are methods of preparing a matrix, and methods of using a matrix in the repair of tissue. In certain configurations, a matrix can comprise a polyester cross-linked with a polysaccharide, which can be an oxidized polysaccharide. In some configurations, a matrix can further comprise one or more additional components, such as a growth factor or an anti-infective agent. In some configurations, a matrix can be a viscous fluid or a paste, while in other configurations a matrix can be comprised by a solid such as a plug, a granule or a membrane. | 10-20-2011 |
20140308251 | INTERVERTEBRAL DISC REPAIR, METHODS AND DEVICES THEREFOR - The present application discloses compositions, methods and devices for treatment of a degenerative intervertebral disc. A composition can comprise chondrocytes expressing type II collagen. These chondrocytes can be obtained from human cadavers up to about two weeks following death, and can be grown in vitro. The compositions can further comprise one or more biocompatible molecules. Treatment of a degenerative disc can comprise injecting or implanting a composition comprising the chondrocytes into a degenerative disc through an aperture or incision. If the aperture or incision is closed with a suture or a glue after introduction of the chondrocytes, the closure can withstand over 400 N of compression force. | 10-16-2014 |
Patent application number | Description | Published |
20130216184 | CONFIGURABLE PITCH REDUCING OPTICAL FIBER ARRAY - The inventive optical fiber coupler array is capable of providing a low loss, high-coupling coefficient interface with high accuracy and easy alignment between a plurality of optical fibers (or other optical devices) with a first channel-to-channel spacing, and an optical device having a plurality of closely-spaced waveguide interfaces with a second channel-to-channel spacing, where each end of the optical fiber coupler array is configurable to have different channel-to-channel spacing, each matched to a corresponding one of the first and second channel-to-channel spacing. The novel optical coupler array includes a plurality of waveguides (at least one of which may optionally be polarization maintaining), that comprises at least one gradually reduced vanishing core fiber, at least in part embedded within a common housing structure. Alternatively, the novel coupler array may be configured for utilization with at least one of an optical fiber amplifier and an optical fiber laser. | 08-22-2013 |
20130301991 | CONFIGURABLE PITCH REDUCING OPTICAL FIBER ARRAY - The inventive optical fiber coupler array is capable of providing a low loss, high-coupling coefficient interface with high accuracy and easy alignment between a plurality of optical fibers (or other optical devices) with a first channel-to-channel spacing, and an optical device having a plurality of closely-spaced waveguide interfaces with a second channel-to-channel spacing, where each end of the optical fiber coupler array is configurable to have different channel-to-channel spacing, each matched to a corresponding one of the first and second channel-to-channel spacing. The novel optical coupler array includes a plurality of waveguides (at least one of which may optionally be polarization maintaining), that comprises at least one gradually reduced vanishing core fiber, at least in part embedded within a common housing structure. Alternatively, the novel coupler array may be configured for utilization with at least one of an optical fiber amplifier and an optical fiber laser. | 11-14-2013 |
20140294345 | OPTICAL COMPONENT ASSEMBLY FOR USE WITH AN OPTICAL DEVICE - The inventive optical component assembly advantageously enables a multi-waveguide optical component (such as the inventive optical fiber coupler array, a multi-core optical fiber, etc.), to be coupled to at least one waveguide of an optical device at a predefined coupling angle. The optical component assembly of the present invention comprises a multi-waveguide optical component with an output end, a prism having an input surface, an output surface, and an internal reflective surface with a predefined reflection angle, and a GRIN lens, positioned between the component output end and the prism input surface, along a longitudinal axis of the multi-waveguide optical component. In accordance with the present invention, the length of the GRIN lens, and its refractive index gradient profile are optimized to form an optical image of the output end of the multi-waveguide optical component, at the output surface of the prism, thus enabling the output surface of the prism to be coupled to at least one waveguide of an optical device, with the predefined reflection angle corresponding to the angle at which the multi-waveguide optical component may be coupled to the optical device. | 10-02-2014 |
Patent application number | Description | Published |
20090035251 | METHOD OF APPLYING AN INJECTABLE FILLER - Methods for applying injectable fillers are provided. In some embodiments, the methods can extend effectiveness of the injectable filler. In some embodiments, the methods can provide for an elevated level of effectiveness of the injectable filler. In some embodiments, the methods can prolong the effectiveness of the injectable filler. | 02-05-2009 |
20090131521 | Aqueous retinoid and benzoyl peroxide gel - Embodiments of this invention relate to a composition containing both benzoyl peroxide and a retinoid. Additionally, it relates to the treatment of acne vulgaris by applying an aqueous gel comprising BPO and a retinoid. | 05-21-2009 |
20090176750 | Compositions and methods for enhancing corticosteroid delivery - The present invention comprises a composition, method of enhancing potency and method of delivering corticosteroids in a vehicle comprising at least two penetration enhancers, and solvents and emulsifiers. The propylene glycol and penetration enhancers are present in ratio to the total of the propylene glycol, penetration enhancers, and solvents and emulsifiers of at least about 0.70. | 07-09-2009 |
20090204101 | METHOD OF APPLYING AN INJECTABLE FILLER - Methods for applying injectable fillers are provided. In some embodiments, the methods can result in a reduced risk of an adverse event occurring from the administration of the injectable filler. Also disclosed are devices and kits related to this method. | 08-13-2009 |
20110082391 | METHODS FOR MEASURING CHANGE IN LIP SIZE AFTER AUGMENTATION - A method for measuring the effect of a medical treatment on the size of lips. The method has the following steps: (a) providing a scale of at least four visual reference images exhibiting varying lip sizes and assigning a unique indicator to each of the at least four visual reference images; (b) visually examining a lip of a human subject to be augmented and selecting one from among of at least four different reference images most closely corresponding in lip size and identifying the corresponding unique indicator; (c) introducing into the lip of the human subject a filler or an implant to augment the size of the lip; (d) visually examining the lip after introduction of the filler or the implant and selecting one of the at least four different reference images most closely corresponding in lip size and identifying the corresponding unique indicator; and (e) comparing the unique indicator of the lip before introduction of the filler or the implant and the unique indicator of the lip after introduction of the filler or the implant to determine if they are different. There is also a method for counseling a human subject undertaking augmentation of lips. There is also a method for developing a scale for measuring differences in lip size in human subjects. There is also a method for determining the amount of filler or implant needed to augment the lips of a human subject. | 04-07-2011 |
20120115954 | Aqueous retinoid and benzoyl peroxide gel - Embodiments of this invention relate to a composition containing both benzoyl peroxide and a retinoid. Additionally, it relates to the treatment of acne vulgaris by applying an aqueous gel comprising BPO and a retinoid. | 05-10-2012 |
20120289490 | COMPOSITIONS AND METHODS FOR ENHANCING CORTICOSTEROID DELIVERY - The present invention comprises a composition, method of enhancing potency and method of delivering corticosteroids in a vehicle comprising at least two penetration enhancers, and solvents and emulsifiers. The propylene glycol and penetration enhancers are present in ratio to the total of the propylene glycol, penetration enhancers, and solvents and emulsifiers of at least about 0.70. | 11-15-2012 |
20130274223 | METHOD OF APPLYING AN INJECTABLE FILLER - Methods for applying injectable fillers are provided. In some embodiments, the methods can extend effectiveness of the injectable filler. In some embodiments, the methods can provide for an elevated level of effectiveness of the injectable filler. In some embodiments, the methods can prolong the effectiveness of the injectable filler. | 10-17-2013 |
20150132267 | FIBROBLAST MIXTURES AND METHODS OF MAKING AND USING THE SAME - The present disclosure provides a non-autologous product that is a mixture of two or more cells or tissue cultures of fibroblast, or extracts from cultures, or media cultures, isolated from separate individuals, either homogeneous or heterogeneous. The cells or factors are blended together in a product that imparts desired characteristics to the skin of a recipient who is not a source of the mixture. The present disclosure also relates to methods of making and using and/or culturing the fibroblasts including to optimize the potency of the mixture to impart one or more the desired characteristics to the skin of a recipient. | 05-14-2015 |